Dr. Lamanna Discusses the MURANO Trial in CLL
January 2nd 2019Nicole Lamanna, MD, associate professor of medicine, Hematologic Malignancies Section, Division of Hematology/Oncology, NewYork-Presbyterian/Columbia University Medical Center, discusses the MURANO trial in patients with chronic lymphocytic leukemia.
Read More
Dr. Lamanna on Incorporating Novel and Traditional Therapies in CLL
May 15th 2015Nicole Lamanna, MD, Associate Professor of Clinical Medicine, Columbia University Medical Center, discusses incorporating novel therapies into the standard treatment paradigm for patients with chronic lymphocytic leukemia (CLL).
Read More